From November 12 to 14, the world's first inhalable new crown vaccine was unveiled at the "2021 Fifth Hainan International Health Industry Expo". The audience can experience the use of inhaled new crown vaccine on site.
It is understood that the same kind of vaccine is used for the inhaled new crown vaccine and intramuscular injection, and the formulation of the vaccine has not changed, only a different method of administration is adopted.
Nebulized inhalation immunity uses a nebulizer to atomize the vaccine into tiny particles, which enter the respiratory tract and lungs through oral inhalation, thereby stimulating mucosal immunity, which cannot be brought by intramuscular injection.
The world's first inhaled new crown vaccine was developed by the team of Academician Chen Wei of the Academy of Military Medicine and Cansino Biological Co., Ltd. At present, the Phase II clinical trial has achieved phased results, and the application for emergency use is being promoted.